The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...

iDenfy’s revamped AML Screening software now includes new risk categories, better PEP status labeling, and other built-in AML features Delaware, United States, October 29, 2025-- iDenfy, a global ...

A detailed to-do list for SEC-registered firms to build a foundation for compliant and effective anti-money laundering ...

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.

South Korea’s FIU fined Korbit $1.9 million after uncovering widespread AML violations, KYC breaches, and unregistered ...

VIENNA (Reuters) - Roughly 15 Swiss banks are in a "red zone" of lenders particularly exposed to money laundering risks, the head of Swiss banking watchdog FINMA said in a newspaper interview ...

South Korea fines Korbit $1.9M for 22,000 AML breaches, citing weak customer checks and unreported overseas transfers.